MX2015001788A - Metabolitos de metionina predicen la evolución agresiva del cáncer. - Google Patents
Metabolitos de metionina predicen la evolución agresiva del cáncer.Info
- Publication number
- MX2015001788A MX2015001788A MX2015001788A MX2015001788A MX2015001788A MX 2015001788 A MX2015001788 A MX 2015001788A MX 2015001788 A MX2015001788 A MX 2015001788A MX 2015001788 A MX2015001788 A MX 2015001788A MX 2015001788 A MX2015001788 A MX 2015001788A
- Authority
- MX
- Mexico
- Prior art keywords
- systems
- methods
- subject
- level
- recurrence
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
- G01N33/587—Nanoparticles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6806—Determination of free amino acids
- G01N33/6812—Assays for specific amino acids
- G01N33/6815—Assays for specific amino acids containing sulfur, e.g. cysteine, cystine, methionine, homocysteine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/54—Determining the risk of relapse
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Computational Biology (AREA)
- General Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
La invención se refiere al uso de enzimas, nanobarras y dispositivos nanoeléctronicos para detectar el nivel de cisteína en una muestra de un paciente y se refiere al uso del nivel de cisteina detectado para predecir la reaparición de cáncer en el paciente y para indicar y/o administrar una terapia adecuada a un sujeto. La invención se refiere a sistemas y métodos para detectar el nivel de cisteina en una muestra de un sujeto, donde los sistemas o métodos también pueden comprender medir al menos un parámetro adicional, tal como nivel de PSA, puntuación de Gleason y etapa clínica. La invención se refiere a sistemas y métodos para predecir la probabilidad de reaparición de un cáncer en un sujeto, donde los sistemas o métodos también pueden comprender medir al menos un parámetro adicional, tal como nivel de PSA, puntuación de Gleason y etapa clínica. La invención comprende además indicar y/o administrar una terapia adecuada a un sujeto en función de la probabilidad prevista de reaparición.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261682155P | 2012-08-10 | 2012-08-10 | |
PCT/US2013/054415 WO2014026157A2 (en) | 2012-08-10 | 2013-08-09 | Methionine metabolites predict aggressive cancer progression |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2015001788A true MX2015001788A (es) | 2015-09-28 |
Family
ID=50066469
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015001788A MX2015001788A (es) | 2012-08-10 | 2013-08-09 | Metabolitos de metionina predicen la evolución agresiva del cáncer. |
Country Status (6)
Country | Link |
---|---|
US (1) | US20140045193A1 (es) |
EP (1) | EP2882862A4 (es) |
AU (1) | AU2013299409A1 (es) |
CA (1) | CA2880928A1 (es) |
MX (1) | MX2015001788A (es) |
WO (1) | WO2014026157A2 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2975895A1 (en) * | 2015-02-12 | 2016-08-18 | Cedars-Sinai Medical Center | Device, system and method for cancer prognosis and uses thereof |
CZ306945B6 (cs) * | 2015-04-23 | 2017-10-04 | Smart Brain s.r.o. | 14-Merkaptotetradecyl-trimethylammonium-bromid, vhodný jako surfaktant pro zlaté nanotyčinky |
CN109146335B (zh) * | 2018-10-10 | 2021-08-20 | 华北电力科学研究院有限责任公司 | 判断10kV线路电能表系统变比与实际变比一致性的方法 |
CN110849815B (zh) * | 2019-12-02 | 2022-10-18 | 中国工程物理研究院激光聚变研究中心 | 一种预测光学元件表面激光损伤性能的方法和系统 |
JP2023533959A (ja) * | 2020-07-08 | 2023-08-07 | ボード オブ レジェンツ,ザ ユニバーシティ オブ テキサス システム | 前立腺がんの検出及び治療方法 |
WO2022087593A1 (en) * | 2020-10-20 | 2022-04-28 | Baylor College Of Medicine | Multiplex metabolic markers in plasma for early detection of african american prostrate cancer |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4940658A (en) * | 1986-11-20 | 1990-07-10 | University Patents, Inc. | Assay for sulfhydryl amino acids and methods for detecting and distinguishing cobalamin and folic acid deficency |
US5559038A (en) * | 1994-05-04 | 1996-09-24 | The Regents Of The University Of Colorado | Gas chromatography/mass spectrometry determination of oxidized sulfhydryl amino acids |
US6174696B1 (en) * | 1999-11-12 | 2001-01-16 | Genzyme Corporation | Method for the determination of homocysteine |
US6664073B1 (en) * | 1999-11-02 | 2003-12-16 | Catch Inc. | Enzymatic cycling assays for homocysteine and cystathionine |
US8346482B2 (en) * | 2003-08-22 | 2013-01-01 | Fernandez Dennis S | Integrated biosensor and simulation system for diagnosis and therapy |
US20060284218A1 (en) * | 2003-09-03 | 2006-12-21 | The Regents Of The University Of California | Nanoelectonic devices based on nanowire networks |
US20100166870A1 (en) * | 2006-12-21 | 2010-07-01 | The University Of Western Australia | Method for Coating Nanoparticles |
CN102150037B (zh) * | 2008-07-11 | 2014-06-04 | 康奈尔大学 | 集成电荷传感器的纳米流体通道及基于该纳米流体通道的方法 |
US20120041274A1 (en) * | 2010-01-07 | 2012-02-16 | Myriad Genetics, Incorporated | Cancer biomarkers |
-
2013
- 2013-08-09 CA CA2880928A patent/CA2880928A1/en not_active Abandoned
- 2013-08-09 US US13/963,922 patent/US20140045193A1/en not_active Abandoned
- 2013-08-09 AU AU2013299409A patent/AU2013299409A1/en not_active Abandoned
- 2013-08-09 EP EP13828540.8A patent/EP2882862A4/en not_active Withdrawn
- 2013-08-09 MX MX2015001788A patent/MX2015001788A/es unknown
- 2013-08-09 WO PCT/US2013/054415 patent/WO2014026157A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US20140045193A1 (en) | 2014-02-13 |
AU2013299409A1 (en) | 2015-02-26 |
WO2014026157A3 (en) | 2014-05-08 |
EP2882862A4 (en) | 2016-07-20 |
WO2014026157A2 (en) | 2014-02-13 |
CA2880928A1 (en) | 2014-02-13 |
EP2882862A2 (en) | 2015-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2015001788A (es) | Metabolitos de metionina predicen la evolución agresiva del cáncer. | |
PH12016501206A1 (en) | The use of inhibitors of bruton`s tyrosine kinase (btk) | |
TN2013000358A1 (en) | Fgfr and ligands thereof as biomarkers for breast cancer in hr positive subjects | |
UA78641U (ru) | Способ прогнозирования тяжести больных острым панкреатитом | |
WO2014009055A9 (en) | Method and kit for predicting or monitoring the response of a cancer patient to chemotherapy, based on measuring the expression level of tmem45a gene. | |
UA82125U (ru) | Способ прогнозирования рефрактур у больных с ложными суставами | |
UA96067U (uk) | Спосіб прогнозування зрощення перелому | |
UA96073U (uk) | Спосіб прогнозування зрощення перелому | |
UA96011U (uk) | Спосіб прогнозування зрощення перелому | |
UA96013U (uk) | Спосіб прогнозування зрощення перелому | |
UA95590U (uk) | Спосіб прогнозування зрощення перелому | |
UA95973U (uk) | Спосіб прогнозування зрощення перелому | |
UA95662U (uk) | Спосіб прогнозування зрощення перелому | |
UA96076U (uk) | Спосіб прогнозування зрощення перелому | |
UA95972U (uk) | Спосіб прогнозування зрощення перелому | |
UA96515U (uk) | Спосіб прогнозування зрощення перелому | |
UA96111U (uk) | Спосіб прогнозування зрощення перелому | |
UA95587U (uk) | Спосіб прогнозування зрощення перелому | |
UA95937U (uk) | Спосіб прогнозування зрощення перелому | |
UA96069U (uk) | Спосіб прогнозування зрощення перелому | |
UA96926U (uk) | Спосіб прогнозування зрощення перелому | |
UA95567U (uk) | Спосіб прогнозування зрощення перелому | |
UA96045U (uk) | Спосіб прогнозування зрощення перелому | |
UA96046U (uk) | Спосіб прогнозування зрощення перелому | |
UA96126U (uk) | Спосіб прогнозування зрощення перелому |